Tuberculosis and antimicrobial resistance - new models of research and development needed

Affiliations

¹ The International Union Against TB and Lung Disease, 68 Boulevard Saint-Michel, 75006, Paris, France.
² Stop TB Partnership, Geneva, Switzerland.
³ South African Medical Research Council, Cape Town, South Africa.
⁴ Critical Path Institute, Tucson, United States of America (USA).
⁵ Global Tuberculosis Community Advisory Board, Cape Town, South Africa.
⁶ Department of Health, Pretoria, South Africa.
⁷ Medicines Patent Pool, Geneva, Switzerland.
⁸ Global Alliance for TB Drug Development, New York, USA.
⁹ Indian Council of Medical Research, New Delhi, India.
¹⁰ Médecins Sans Frontières Access Campaign, Geneva, Switzerland.
¹¹ Médecins Sans Frontières, Amsterdam, Netherlands.

Editorial

Grania Brigden et al. Bull World Health Organ. 2017.

. 2017 May 1;95(5):315.

doi: 10.2471/BLT.17.194837.

¹ The International Union Against TB and Lung Disease, 68 Boulevard Saint-Michel, 75006, Paris, France.
² Stop TB Partnership, Geneva, Switzerland.
³ South African Medical Research Council, Cape Town, South Africa.
⁴ Critical Path Institute, Tucson, United States of America (USA).
⁵ Global Tuberculosis Community Advisory Board, Cape Town, South Africa.
⁶ Department of Health, Pretoria, South Africa.
⁷ Medicines Patent Pool, Geneva, Switzerland.
⁸ Global Alliance for TB Drug Development, New York, USA.
⁹ Indian Council of Medical Research, New Delhi, India.
¹⁰ Médecins Sans Frontières Access Campaign, Geneva, Switzerland.
¹¹ Médecins Sans Frontières, Amsterdam, Netherlands.

No abstract available

References

1. Global tuberculosis report 2016. Geneva: World Health Organization; 2016. Available from: http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?... [cited 2 April 2017].
1. 2016 report on tuberculosis research funding trends, 2005–2015: no time to lose. New York: Treatment Action Group; 2016. Available from: http://www.treatmentactiongroup.org/sites/default/files/TB_FUNDING_2016_... [cited 4 April 2017].
1. Tackling drug-resistant infections globally: final report and recommendations. London: The Review on Antimicrobial Resistance; 2016. Available from: https://amr-review.org/sites/default/files/160525_Final%20paper_with%20c... [cited 2 April 2017].
1. Research and development to meet health needs in developing countries: strengthening global financing and coordination. Geneva: World Health Organization; 2012. Available from: http://apps.who.int/iris/bitstream/10665/254706/1/9789241503457-eng.pdf?... [cited 2 April 2017].
1. Report of the United Nations Secretary-General’s High-Level Panel on Access to Medicines. New York: United Nations Secretary-General’s High-Level Panel on access to medicines; 2016. Available from: https://static1.squarespace.com/static/562094dee4b0d00c1a3ef761/t/57d9c6... [cited 2 April 2017].